Great ASCO announcements on patient genetics testing to guide cancer treatment
ASCO meeting took place virtually this year due to Covid-19. But it didn't fall short of exciting announcements that will shape the future of Oncology treatments.
In particular, great announcements were made by companies like Exact Sciences, Guardant Health, or Oncocyte about patient genetics testing and how they will help guide cancer treatment. This will improve targeted usage of checkpoint inhibitors, and CAR-T for the most relevant tumor sub-types.
#immunooncology #postcovid19 #bluejetconsulting